10
Participants
Start Date
October 1, 2020
Primary Completion Date
June 30, 2024
Study Completion Date
December 31, 2024
Cenegermin-Bkbj 0.002% Ophthalmic Solution [OXERVATE]
Research subjects will use oxervate in affected eye following approved treatment regimen and have their eye measured with optical coherence tomography and a Cochet-Bonnet esthesiometer at various time points before, during and after treatment.
RECRUITING
SightMD, Manhasset
Dompé, US, Inc.
UNKNOWN
Sight Medical Doctors PLLC
OTHER